Shares of Healthequity Inc (NASDAQ:HQY) have received a consensus rating of “Buy” from the twelve brokerages that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and ten have issued a buy recommendation on the company. The average 1 year price target among analysts that have covered the stock in the last year is $56.67.
A number of research firms have recently weighed in on HQY. Zacks Investment Research raised shares of Healthequity from a “hold” rating to a “buy” rating and set a $57.00 price target on the stock in a research note on Saturday, February 10th. BidaskClub raised shares of Healthequity from a “hold” rating to a “buy” rating in a research note on Friday. Robert W. Baird upped their price target on shares of Healthequity from $48.00 to $49.00 and gave the stock a “neutral” rating in a research note on Wednesday, February 7th. Cantor Fitzgerald upped their price target on shares of Healthequity from $56.00 to $60.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 7th. Finally, JPMorgan Chase & Co. lowered their price target on shares of Healthequity from $52.00 to $51.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 24th.
In related news, insider Jon Kessler sold 20,442 shares of the stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $55.02, for a total value of $1,124,718.84. Following the sale, the insider now directly owns 446,332 shares of the company’s stock, valued at approximately $24,557,186.64. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, major shareholder Berkley Capital, Llc sold 700 shares of the stock in a transaction dated Wednesday, November 29th. The shares were sold at an average price of $52.05, for a total transaction of $36,435.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 751,040 shares of company stock worth $38,610,529. 19.00% of the stock is owned by corporate insiders.
Healthequity (NASDAQ HQY) traded up $0.15 during trading hours on Friday, hitting $54.86. 557,200 shares of the stock were exchanged, compared to its average volume of 526,513. Healthequity has a fifty-two week low of $37.62 and a fifty-two week high of $56.81. The firm has a market cap of $3,328.50, a PE ratio of 74.14, a PEG ratio of 2.09 and a beta of 1.70.
Healthequity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, December 5th. The company reported $0.17 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.13 by $0.04. Healthequity had a net margin of 21.08% and a return on equity of 14.47%. The business had revenue of $56.80 million for the quarter, compared to analysts’ expectations of $55.27 million. During the same period in the prior year, the company posted $0.10 EPS. The business’s revenue for the quarter was up 31.0% on a year-over-year basis. sell-side analysts forecast that Healthequity will post 0.73 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: This report was posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this report on another site, it was copied illegally and reposted in violation of international trademark and copyright law. The correct version of this report can be read at https://stocknewstimes.com/2018/02/20/brokerages-set-healthequity-inc-hqy-target-price-at-56-67.html.
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.